Sensei Biotherapeutics Inc
F:407
Sensei Biotherapeutics Inc
F:407
Price:
5.2
EUR
Market Cap:
€138.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Sensei Biotherapeutics Inc
F:407
|
US |
|
G
|
Gold Lion Resources Inc
CNSX:GL
|
CA |
|
Komatsu Ltd
F:KOMA
|
JP |
|
A
|
Armada Mercantile Ltd
CNSX:ARM
|
CA |
|
Wallenius Wilhelmsen ASA
OSE:WAWI
|
NO |
|
E
|
EQV Ventures Acquisition Corp
NYSE:EQV
|
US |
|
Prairie Provident Resources Inc
TSX:PPR
|
CA |
|
G
|
GeneralFinance SpA
MIL:GF
|
IT |
|
S
|
Sanofi SA
XHAM:SNW
|
FR |
|
Maritime Resources Corp
XTSX:MAE
|
CA |
|
Thrive Tribe Technologies Ltd
ASX:1TT
|
AU |
|
O
|
Organon Pharma Indonesia Tbk PT
IDX:SCPI
|
ID |
|
U
|
Unitronix Corp
OTC:UTRX
|
US |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of Sensei Biotherapeutics Inc.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
Competitors Multiples
Sensei Biotherapeutics Inc Competitors
Sensei Biotherapeutics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Sensei Biotherapeutics Inc
F:407
|
38.1m EUR | 0 | -1.8 | -0.8 | -0.8 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
364.8B USD | 6 | 87.2 | 14.5 | 20.1 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
183.3B USD | 5 | 23.7 | 13.8 | 13.8 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
172.3B USD | 5.9 | 20.3 | 12.7 | 15.6 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
109.7B USD | 9.1 | 27.7 | 20.8 | 21.7 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.4B USD | 5.6 | 17.8 | 13.3 | 15.2 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.6B AUD | 3 | 33.6 | 11.3 | 14.2 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.7B EUR | 11.7 | 37.5 | 40.9 | 41.7 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
